Waldencast plc(WALD)

Search documents
Waldencast plc(WALD) - 2024 Q4 - Annual Report
2025-03-20 20:06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934: For the fiscal year ended December 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR o SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF ...
Waldencast plc(WALD) - 2024 Q4 - Earnings Call Presentation
2025-03-19 19:01
DISCLAIMER Cautionary Statement Regarding Forward-Looking Statements All statements in this release that are not historical, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about: Waldencast's outlook and guidance for 2025; our ability to deliver financial results in line with expectations; expectations regarding sales, earnings or other future financial performance ...
Waldencast plc(WALD) - 2024 Q4 - Earnings Call Transcript
2025-03-19 18:59
Waldencast plc (NASDAQ:WALD) Q4 2024 Earnings Conference Call March 19, 2025 8:30 AM ET Company Participants Allison Malkin - Investor Relations Michel Brousset - Founder and Chief Executive Officer Manuel Manfredi - Chief Financial Officer Conference Call Participants Jonna Kim - TD Cowen Ashley Helgans - Jefferies Linda Bolton Weiser - D.A. Davidson Olivia Tong - Raymond James Operator Greetings, welcome to the Waldencast Fourth Quarter and Fiscal Year 2024 Earnings Call. At this time, all participants ar ...
Waldencast Reports Q4 2024 and Fiscal Year 2024 Financial Results
GlobeNewswire· 2025-03-18 20:15
Q4 Net Revenue of $72.1 million, 29.4% Comparable Net Revenue Growth and $11.2 million of Adjusted EBITDA, doubling from Q4 2023 FY 2024 Net Revenue of $273.9 million, 27.5% Comparable Net Revenue Growth and $40.3 million of Adjusted EBITDA Obagi Medical is the fastest growing professional skincare brand1 in the US in 2024 Milk Makeup expands its distribution to Ulta Beauty Waldencast secures a new $205 million credit facility, replacing the current one, enhancing flexibility and extending debt maturity LON ...
Waldencast plc Announces Fourth Quarter and Fiscal Year 2024 Results Conference Call and Webcast
GlobeNewswire· 2025-03-11 20:05
LONDON, March 11, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform provided the details for its Fourth Quarter and Fiscal Year 2024 conference call and webcast. As previously announced, the Company will issue its Fourth Quarter and Fiscal Year 2024 results on March 18, 2025 after the close of the U.S. market. Management will host a conference call to discuss its Fourth Quarter and Fiscal Year 2024 results on March 19, 2025 at 8:30am ET ...
Waldencast Announces Participation in the TD Cowen 2nd Annual Glowing Ahead: Beauty & Wellness Summit
GlobeNewswire· 2025-02-19 21:05
Core Insights - Waldencast plc is participating in the TD Cowen 2 Annual Glowing Ahead: Beauty & Wellness Summit on February 26, 2025, in New York [1] - CEO Michel Brousset will engage in a fireside chat presentation and host investor meetings during the summit [2] - Waldencast aims to build a global beauty and wellness platform by developing and scaling purpose-driven brands, with a focus on operational efficiency and market responsiveness [3] Company Overview - Waldencast was founded by Michel Brousset and Hind Sebti, with a vision to create a best-in-class beauty and wellness operating platform [3] - The company’s strategy includes acquiring and accelerating high-growth brands while maintaining their unique identities [3] - The initial step in this strategy was the business combination with Obagi Skincare and Milk Makeup, which allows brands to leverage operational scale and expertise [3]
Obagi Medical Announces the Launch of Latest Innovations in The SUZANOBAGIMD® Collection
GlobeNewswire· 2025-02-10 14:00
New Skincare Solutions to Target Skin Brightening, Oxidative Stress, and Hydration for a Healthier, More Radiant Complexion NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Obagi Medical (“Obagi”), a leader in advanced skincare innovation and the originator of medical-grade skincare, proudly unveils the latest groundbreaking additions to its highly regarded SUZANOBAGIMD® collection. The new products - Super Antioxidant Serum and Moisture Restore Hydration Replenishing Cream - offer cutting-edge solutions to addr ...
Waldencast plc Announces Upcoming Earnings Release and Conference Call Dates
GlobeNewswire· 2025-01-30 21:05
LONDON, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, announced upcoming earnings release, conference call and webcast information for the fourth quarter and full fiscal year 2024 and first, second, and third quarters of fiscal year 2025. The webcasts will be available on the Investor Relations page on the company's website at https://ir.waldencast.com/ approximately 2 weeks prior to the events. For the fourth quarter and ...
Waldencast Announces Participation in the 2025 IMCAS World Congress
GlobeNewswire· 2025-01-29 12:00
Core Insights - Waldencast plc is participating in the 2025 International Master Course on Aging Science (IMCAS) World Congress in Paris from January 30 to February 1, 2025, highlighting its commitment to the beauty and wellness industry [1][2] Company Overview - Waldencast aims to build a global best-in-class beauty and wellness platform by developing, acquiring, and scaling purpose-driven brands, with a focus on maintaining each brand's distinct identity [4] - The company has already taken significant steps by combining with Obagi Skincare and Milk Makeup, which will allow its brands to benefit from operational scale and market responsiveness [4] Industry Participation - The IMCAS World Congress is a key event for dermatology, plastic surgery, and aging science, bringing together industry leaders to discuss innovations and business opportunities [2] - Michel Brousset, CEO of Waldencast, will participate in a capital markets roundtable to discuss the future of medical-grade skincare and the beauty industry [2] Expert Contributions - Dr. Suzan Obagi, Chief Medical Director at Obagi Medical, will lead sessions on enhancing skincare results and addressing complications related to energy-based devices, as well as a symposium on hyperpigmentation [3]
Waldencast Announces Participation in the ICR Conference 2025
GlobeNewswire· 2025-01-06 21:05
Core Viewpoint - Waldencast plc, a global multi-brand beauty and wellness platform, is set to participate in investor meetings and host a presentation at the ICR Conference 2025 on January 13, 2025 [1][2]. Company Overview - Waldencast was founded by Michel Brousset and Hind Sebti, aiming to create a best-in-class beauty and wellness operating platform by developing, acquiring, and scaling purpose-driven brands [3]. - The company's brand-led business model focuses on customer proximity, business agility, and market responsiveness while preserving each brand's unique identity [3]. - The initial step towards this vision was the business combination with Obagi Skincare and Milk Makeup, which allows its brands to leverage operational scale and expertise in managing global beauty brands [3].